Patent ID: 8592370
Filing Date: 2013-11-26
Classification: A61K,A61P,Y10S

Abstract:
1. A pharmaceutical composition comprising insulin in combination with at least one compound of formula (I) and/or physiologically acceptable salts thereof, wherein the compound of formula (I) is defined as follows: in which R R R R Ar denotes phenyl, naphthyl or biphenyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OA, OH, COOH, COOA, CN, NH Het denotes a mono-, bi- or tricyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di- or trisubstituted by Hal, A, OH, OA, NH A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms may be replaced by F, or cyclic alkyl having 3-7 C atoms, Hal denotes F, Cl, Br or I, m denotes 1, 2, 3, 4, 5 or 6, and n denotes 0, 1 or 2.